Literature DB >> 26311749

Iron chelation therapy to prevent the manifestations of aceruloplasminemia.

Francesco Bove1, Alfonso Fasano2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26311749     DOI： 10.1212/WNL.0000000000001956

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  Aceruloplasminemia with Abnormal Compound Heterozygous Mutations Developed Neurological Dysfunction during Phlebotomy Therapy.

Authors:  Maki Watanabe; Ken Ohyama; Masashi Suzuki; Yasunobu Nosaki; Takashi Hara; Katsushige Iwai; Satoshi Kono; Hiroaki Miyajima; Kenji Mokuno
Journal:  Intern Med       Date:  2018-04-27       Impact factor: 1.271

Review 2.  Inherited Disorders of Iron Overload.

Authors:  Kostas Pantopoulos
Journal:  Front Nutr       Date:  2018-10-29

Review 3.  Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders.

Authors:  Vassilena Iankova; Ivan Karin; Thomas Klopstock; Susanne A Schneider
Journal:  Front Neurol       Date:  2021-04-15       Impact factor: 4.003

Review 4.  Mechanistic Insights of Chelator Complexes with Essential Transition Metals: Antioxidant/Pro-Oxidant Activity and Applications in Medicine.

Authors:  Viktor A Timoshnikov; Olga Yu Selyutina; Nikolay E Polyakov; Victoria Didichenko; George J Kontoghiorghes
Journal:  Int J Mol Sci       Date:  2022-01-23       Impact factor: 5.923

5.  A New Pathogenic Missense Variant in a Consanguineous North-African Family Responsible for a Highly Variable Aceruloplasminemia Phenotype: A Case-Report.

Authors:  Hervé Lobbes; Quitterie Reynaud; Sabine Mainbourg; Claire Savy-Stortz; Martine Ropert; Edouard Bardou-Jacquet; Stéphane Durupt
Journal:  Front Neurosci       Date:  2022-05-02       Impact factor: 4.677

Review 6.  The non-Huntington disease choreas: Five new things.

Authors:  Ruth H Walker
Journal:  Neurol Clin Pract       Date:  2016-04

7.  Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports.

Authors:  Lena H P Vroegindeweij; Agnita J W Boon; J H Paul Wilson; Janneke G Langendonk
Journal:  Orphanet J Rare Dis       Date:  2020-04-25       Impact factor: 4.123
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.